Pre-exposure Prophylaxis Recent Adherence With Real-Time Adherence Feedback and Partner Human Immunodeficiency Virus Self-Testing: A Pilot Trial Among Postpartum Women
Postpartum women who initiated PrEP during pregnancy with the PrEP-PP study were randomized 1:1 to the intervention (HIVST, biofeedback counseling after urine tenofovir test) or to SOC (facility-based HIV test, routine counseling without biofeedback). HIVST for partners and biofeedback counseling increased levels of PrEP adherence.
Resource Details
- Study Type
- Pilot study, Randomized clinical trial (RCT)
- Year
- 2021
- Population
- HIV-uninfected women, Pregnant Women
- Author
- Joseph Davey DL, Dovel K, Mvududu R, Nyemba D, Mashele N, Bekker LG, Gorbach PM, Coates TJ, Myer L.
More Publications & Resources
Standard Operating Procedure for Injectable Lenacapavir as Pre-exposure Prophylaxis
Provider Training Toolkit on Use of Oral and Long Acting HIV PrEP
Site/Facility Readiness Assessment Tool to Support Lenacapavir for HIV Prevention Introduction
Rapid Landscape Analysis of National Vertical Transmission Policies for Inclusion of PrEP for Pregnant and Breastfeeding People
Tools for Active Safety Surveillance of Maternal and Infant Health Outcomes for Pregnant and Breastfeeding Users of Oral PrEP and PrEP Ring
Long-Acting Injectable Antiretroviral Drugs for Pregnant and Breastfeeding Women: Current Advances, Challenges, and Future Directions
Assessment of Facility Readiness for PrEP Provision in Antenatal and Postnatal Care Services
Oral PrEP for PBFP Training Package
Key Considerations for Integration of PrEP for Pregnant and Breastfeeding People into National Prevention of Vertical Transmission Polices
No results found.